Arming An Anti-CD38, Myeloma-Targeting Antibody With An Attenuated IFNα Provides >10,000-Fold Enhanced Tumor-Specific Activity Compared To Native IFNα

Autor: Pogue, Sarah L., Taura, Tetsuya *, Bi, Mingying *, Mikesell, Glen E. *, Yun, Yong *, Sho, Angela *, Sanchez, Eric *, Chen, Haiming, Berenson, James R., Wilson, David S. *
Zdroj: In Blood 15 November 2013 122(21):1956-1956
Databáze: ScienceDirect